Drug Trial Radar · NCT00098124
Study of Milnacipran for the Treatment of Fibromyalgia
Last checked: Nov 20, 2026Latest source record: Dec 24, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Actual
Start
Nov 2004
Primary completion
Not stated
Study completion Dec 2006
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Dec 6, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.
Conditions
- Fibromyalgia
Interventions
milnacipran hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite responder analysis based on pain and patient global status, with or without physical function.
Locations
80 sites in 1 country. Site status is shown where the registry gives one.
Forest Investigative Site
Birmingham, Alabama
Forest Investigative Site
Mobile, Alabama
Forest Investigative Site
Montgomery, Alabama
Forest Investigative Site
Peoria, Arizona
Forest Investigative Site
Beverly Hills, California
Forest Investigative Site
Sacramento, California
Forest Investigative Site
San Diego, California
Forest Investigative Site
San Diego, California
Forest Investigative Site
Santa Ana, California
Forest Investigative Site
Spring Valley, California
Forest Investigative Site
Torrance, California
Forest Investigative Site
Colorado Springs, Colorado
Forest Investigative Site
Colorado Springs, Colorado
Forest Investigative Site
Danbury, Connecticut
Forest Investigative Site
Stamford, Connecticut
Forest Investigative Site
Trumball, Connecticut
Forest Investigative Site
Clearwater, Florida
Forest Investigative Site
DeLand, Florida
Forest Investigative Site
Delray Beach, Florida
Forest Investigative Site
Jacksonville, Florida
Forest Investigative Site
Ocala, Florida
Forest Investigative Site
Ormond Beach, Florida
Forest Investigative Site
Palm Harbor, Florida
Forest Investigative Site
Pembroke Pines, Florida
Forest Investigative Site
Port Orange, Florida
Forest Investigative Site
Tamarac, Florida
Forest Investigative Site
Decatur, Georgia
Forest Investigative Site
Honolulu, Hawaii
Forest Investigative Site
Meridian, Idaho
Forest Investigative Site
Chicago, Illinois
Forest Investigative Site
Libertyville, Illinois
Forest Investigative Site
Peoria, Illinois
Forest Investigative Site
Evansville, Indiana
Forest Investigative Site
Lafayette, Indiana
Forest Investigative Site
Wichita, Kansas
Forest Investigative Site
Lexington, Kentucky
Forest Investigative Site
Baltimore, Maryland
Forest Investigative Site
Columbia, Maryland
Forest Investigative Site
Frederick, Maryland
Forest Investigative Site
Newton, Massachusetts
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.